Olgu Sunumu

Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing

Cilt: 17 Sayı: 1 31 Mart 2026
PDF İndir
TR EN

Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing

Öz

Introduction: Dieulafoy’s lesion (DL) is a rare but potentially life-threatening cause of upper gastrointestinal bleeding. Endoscopic therapy is the first-line treatment; however, recurrent bleeding may necessitate surgical intervention. Case Report:A 55-year-old male presented to the emergency department with hematemesis and hemodynamic instability. Initial endoscopy revealed a Dieulafoy’s lesion in the gastric fundus with active bleeding. Hemostasis was achieved with epinephrine injection, thermal coagulation, and hemoclip placement, and temporary stabilization was obtained after blood transfusion. On the third hospital day, recurrent bleeding required repeat endoscopy and an additional hemoclip application, but the patient continued to experience symptoms. On day eight, intraoperative endoscopic tattooing with methylene blue facilitated accurate localization of the lesion, and wedge resection was performed. The postoperative course was uneventful, and histopathological examination confirmed the diagnosis of DL. Conclusion:This case demonstrates that intraoperative endoscopic marking is a valuable adjunct in refractory Dieulafoy’s lesions, enabling precise localization, avoiding unnecessary radical surgery, and allowing successful limited resection.

Anahtar Kelimeler

Etik Beyan

Hasta, özgür ve bilgilendirilmiş onam formunu imzalamıştır.

Kaynakça

  1. Nojkov B, Cappell MS. Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc. 2015 Apr 16;7(4):295–307. doi: 10.4253/wjge.v7.i4.295
  2. Gallard Lee, Y. T., Walmsley, R. S., Leong, R. W. L., & Sung, J. J. Y. (2003). Dieulafoy’s lesion. Gastrointestinal Endoscopy, 58(2), 236–243. doi:10.1067/mge.2003.328
  3. Chen W, Chen P, Li X, Gao X, Li J. Clinical characteristics and treatments for bronchial Dieulafoy’s disease. Respir Med Case Rep. 2019 Jan 7;26:229-235. doi: 10.1016/j.rmcr.2019.01.004. PMID: 30740302; PMCID: PMC6357209
  4. Veldhuyzen van Zanten, S. J., Bartelsman, J. F., Schipper, M. E., & Tytgat, G. N. (1986). Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut, 27(2), 213–222. doi:10.1136/gut.27.2.213
  5. Jeon HK, Kim GH. Endoscopic Management of Dieulafoy’s Lesion. Clin Endosc. 2015 Mar;48(2):112-20. doi: 10.5946/ce.2015.48.2.112. Epub 2015 Mar 27. PMID: 25844338; PMCID: PMC4381137.
  6. Baxter M, Aly EH. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010 Oct;92(7):548-54. doi: 10.1308/003588410X1269966390531 1. PMID: 20883603; PMCID: PMC3229341.
  7. Norton, I. D., Petersen, B. T., Sorbi, D., Balm, R. K., Alexander, G. L., & Gostout, C. J. (1999). Management and long-term prognosis of Dieulafoy lesion. Gastrointestinal Endoscopy, 50(6), 762–767. doi:10.1016/s0016-5107(99)70155-0
  8. Saleh R, Lucerna A, Espinosa J, Scali V. Dieulafoy lesion: the little known sleeping giant of gastrointestinal bleeds. Am J Emerg Med. 2016 Dec;34(12):2464.e3-2464.e5.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Acil Tıp, Gastroenteroloji ve Hepatoloji

Bölüm

Olgu Sunumu

Yayımlanma Tarihi

31 Mart 2026

Gönderilme Tarihi

3 Eylül 2025

Kabul Tarihi

12 Ocak 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 17 Sayı: 1

Kaynak Göster

APA
Perçem, A. K., Topcu, R., Aslan, O., Yüksek, M. A., & Sezikli, İ. (2026). Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports, 17(1), 37-40. https://doi.org/10.33706/jemcr.1777562
AMA
1.Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 2026;17(1):37-40. doi:10.33706/jemcr.1777562
Chicago
Perçem, Aşkın Kadir, Ramazan Topcu, Orhan Aslan, Mahmut Arif Yüksek, ve İsmail Sezikli. 2026. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports 17 (1): 37-40. https://doi.org/10.33706/jemcr.1777562.
EndNote
Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ (01 Mart 2026) Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports 17 1 37–40.
IEEE
[1]A. K. Perçem, R. Topcu, O. Aslan, M. A. Yüksek, ve İ. Sezikli, “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”, Journal of Emergency Medicine Case Reports, c. 17, sy 1, ss. 37–40, Mar. 2026, doi: 10.33706/jemcr.1777562.
ISNAD
Perçem, Aşkın Kadir - Topcu, Ramazan - Aslan, Orhan - Yüksek, Mahmut Arif - Sezikli, İsmail. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports 17/1 (01 Mart 2026): 37-40. https://doi.org/10.33706/jemcr.1777562.
JAMA
1.Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 2026;17:37–40.
MLA
Perçem, Aşkın Kadir, vd. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports, c. 17, sy 1, Mart 2026, ss. 37-40, doi:10.33706/jemcr.1777562.
Vancouver
1.Aşkın Kadir Perçem, Ramazan Topcu, Orhan Aslan, Mahmut Arif Yüksek, İsmail Sezikli. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 01 Mart 2026;17(1):37-40. doi:10.33706/jemcr.1777562